Biotechnology is a rapidly expanding field that stands to drastically change and improve a number of industries, namely healthcare. As discoveries, applications, and new inventions are unfolding, understanding how biotechnology companies can and should apply for patents is important. However, equally important is the understanding that certain complications can arise when it comes to applying for a biotechnology patent.
One popular development that has recently re-emerged in the press is CRISPR. As the debate over the patentability of CRISPR continues, it becomes important to understand what it is and what the future holds for this technology.
The rapid emergence of new and innovative technology has disrupted traditional practices, especially in the medical industry. One of the developments with a substantial amount of potential is the integration of artificial intelligence (AI) in medical applications.
While the Supreme Court ruled against patenting naturally occurring genes because they are a product of nature rather than invention, a patent established for a non-naturally occurring gene was deemed acceptable.
Welcome to Brenda Entzminger's blog!